Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
EMD Serono
Biotech
Merck KGaA in-office requirement could lead to 70 US layoffs
Employees living more than 50 miles from EMD Serono's Massachusetts R&D site must decide whether to relocate or be laid off.
Darren Incorvaia
Jul 13, 2026 2:32pm
EMD Serono taps in new commercial strategy head—Chutes & Ladders
Jun 26, 2026 8:30am
AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders
Dec 13, 2024 8:30am
EMD Serono taps new COO—Chutes & Ladders
Jul 7, 2023 9:30am
Merck KGaA pays Aqilion €10M to tackle tough autoimmune target
Feb 16, 2023 6:00am
Merck KGaA shrinks US R&D team as layoffs batter industry
Jan 23, 2023 10:00am